Provided by Tiger Trade Technology Pte. Ltd.

ASCENTAGE PHARMA GROUP

14.75
+0.20001.37%
Post-market: 14.750.00000.00%16:10 EDT
Volume:1K
Turnover:17.50K
Market Cap:1.38B
PE:-6.34
High:14.80
Open:14.50
Low:14.50
Close:14.55
52wk High:37.50
52wk Low:14.46
Shares:93.33M
Float Shares:71.58M
Volume Ratio:0.13
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3260
EPS(LYR):-1.9957
ROE:-236.63%
ROA:-28.04%
PB:16.56
PE(LYR):-7.39

Loading ...

Ascentage Pharma: A Dancer on the High Wire

Deep News
·
Yesterday

Ascentage Pharma Group International : JP Morgan Cuts Target Price to $33 from $46

THOMSON REUTERS
·
Oct 08

Ascentage Pharma Trustee Acquires 50,000 Shares for 2022 Restricted Share Unit Scheme

Stock News
·
Sep 17

Analysts Offer Insights on NA Companies: PACS Group Inc (PACS) and Ascentage Pharma Group International Unsponsored ADR (AAPG)

TIPRANKS
·
Sep 02

Ascentage Pharma to Participate in Four Upcoming Investor Conferences

GlobeNewswire
·
Sep 02

Oppenheimer Keeps Their Buy Rating on Ascentage Pharma Group International Unsponsored ADR (AAPG)

TIPRANKS
·
Aug 21

Ascentage Pharma H1 Loss Widens, Revenue Rises

MT Newswires Live
·
Aug 20

Reported Earlier, Ascentage Pharma Group H1 EPS $(0.32) Beats $(0.44) Estimate, Sales $44.541M Beat $24.070M Estimate

Benzinga Earnings
·
Aug 20

Ascentage Pharma Reports 2026 Interim Results: Strengthening Commercial Engine and Accelerating Global Expansion

Stock News
·
Aug 20

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

GlobeNewswire
·
Aug 20

Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit

GlobeNewswire
·
Aug 13

Earning Preview: ASCENTAGE PHARMA GROUP this quarter’s revenue is expected to increase by 58.18%, and institutional views are bullish

Earnings Agent
·
Aug 12

CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

GlobeNewswire
·
Aug 05

Ascentage Pharma appoints Miyara as CBO, Ziegler as CCO

TIPRANKS
·
Aug 03

ASCENTAGE PHARMA GROUP Appoints Two Key Executives to Lead Global Business and Commercial Operations

Stock News
·
Aug 03

Press Release: Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer

Dow Jones
·
Aug 03

Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026

GlobeNewswire
·
Jul 27

Ascentage Pharma files to sell American Depositary Shares, no amount given

TIPRANKS
·
Jul 20

ASCENTAGE PHARMA Announces Grant of 440,700 Restricted Share Units Under 2021 Plan

Stock News
·
Jun 30

Ascentage Pharma announces clinical updates from EHA2026

TIPRANKS
·
Jun 15